Recanalization therapies in acute ischemic stroke patients: impact of prior treatment with novel oral anticoagulants on bleeding complications and outcome.

Publication

Recanalization therapies in acute ischemic stroke patients: impact of prior treatment with novel oral anticoagulants on bleeding complications and outcome.

Journal Paper/Review - Jul 31, 2015

Seiffge David Julian, Hooff Robbert-JanVan, Nolte Christian H, Béjot Yannick, Turc Guillaume, Ikenberg Benno, Berge Eivind, Persike Malte, Dequatre-Ponchelle Nelly, Strbian Daniel, Pfeilschifter Waltraud, Zini Andrea, Tveiten Arnstein, Næss Halvor, Michel Patrik, Sztajzel Roman F, Luft Andreas R, Gensicke Henrik, Traenka Christopher, Hert Lisa, Scheitz Jan F, De Marchis Gian Marco, Bonati Leo H, Peters Nils, Charidimou Andreas, Werring David J, Palm Frederick, Reinhard Matthias, Niesen Wolf-Dirk, Nagao Takehiko, Pezzini Alessandro, Caso Valeria, Nederkoorn Paul J J, Kägi Georg, von Hessling Alexander, Padjen Visnja, Cordonnier Charlotte, Erdur Hebun, Lyrer Philippe A, Brouns Raf, Steiner Thorsten, Tatlisumak Turgut, Engelter Stefan T, NOACISP Study Group*

Citation

Seiffge D, Hooff R, Nolte C, Béjot Y, Turc G, Ikenberg B, Berge E, Persike M, Dequatre-Ponchelle N, Strbian D, Pfeilschifter W, Zini A, Tveiten A, Næss H, Michel P, Sztajzel R, Luft A, Gensicke H, Traenka C, Hert L, Scheitz J, De Marchis G, Bonati L, Peters N, Charidimou A, Werring D, Palm F, Reinhard M, Niesen W, Nagao T, Pezzini A, Caso V, Nederkoorn P, Kägi G, von Hessling A, Padjen V, Cordonnier C, Erdur H, Lyrer P, Brouns R, Steiner T, Tatlisumak T, Engelter S, NOACISP Study Group*. Recanalization therapies in acute ischemic stroke patients: impact of prior treatment with novel oral anticoagulants on bleeding complications and outcome. Circulation 2015; 132:1261-9.

Type

Journal Paper/Review (English)

Journal

Circulation 2015; 132

Publication Date

Jul 31, 2015

Issn Electronic

1524-4539

Pages

1261-9

Brief description/objective

We explored the safety of intravenous thrombolysis (IVT) or intra-arterial treatment (IAT) in patients with ischemic stroke on non-vitamin K antagonist oral anticoagulants (NOACs, last intake <48 hours) in comparison with patients (1) taking vitamin K antagonists (VKAs) or (2) without previous anticoagulation (no-OAC).